Desensitization of donor specific resistant positive lymphocyte cross-match by donor specific mesenchymal stem cell transfusion / Ahmed Atef Fouad Mekky ; Supervised Mohammed Gamal Aldin Saadi , May Abdelmonem Hasab Allah , Mervat Mohammed Saad Elansary
Material type: TextLanguage: English Publication details: Cairo : Ahmed Atef Fouad Mekky , 2014Description: 138 P. : charts , facsimiles ; 25cmOther title:- إزالة التحسس بإنهاء التفاعل التطابقى الإيجابى للخلايا الليمفاوية بخلايا المتبرع الجزعية [Added title page title]
- Issued also as CD
Item type | Current library | Home library | Call number | Copy number | Status | Date due | Barcode | |
---|---|---|---|---|---|---|---|---|
Thesis | قاعة الرسائل الجامعية - الدور الاول | المكتبة المركزبة الجديدة - جامعة القاهرة | Cai01.11.18.M.Sc.2014.Ah.D (Browse shelf(Opens below)) | Not for loan | 01010110065050000 | |||
CD - Rom | مخـــزن الرســائل الجـــامعية - البدروم | المكتبة المركزبة الجديدة - جامعة القاهرة | Cai01.11.18.M.Sc.2014.Ah.D (Browse shelf(Opens below)) | 65050.CD | Not for loan | 01020110065050000 |
Browsing المكتبة المركزبة الجديدة - جامعة القاهرة shelves Close shelf browser (Hides shelf browser)
Thesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Internal Medicine
Background: Donor specific antibodies (DSA) and a positive cross-match in patients who are sensitized through previous blood transfusions, organ transplantation or pregnancy are an important obstacle in kidney transplantation. , trials of allograft transplantation across the HLA barrier have employed desensitization strategies, including the use of plasmapheresis, intravenous immunoglobulins, anti-B-cell monoclonal antibodies and splenectomy, associated with high-intensity immunosuppressive regimens. These measures have proven only partially successful in preventing or treating humoral rejection in high-risk patients, while causing a significant increase in the risk of severe infectious complications occurring after transplantation. Mesenchymal stem cells (MSCs) have immunomodulatory capacity and are able to suppress allo-specific antibody production in vitro, and may therefore help overcome a positive cross-match in sensitized transplant recipients. Aim of the Work: To evaluate the effect of mesenchymal stem cell transfusion on desensitization of donor specific resistant positive lymphocyte cross-match and /or high titre Panel Reactive Antibody (PRA)
Issued also as CD
There are no comments on this title.